Construction of Pfizer-sponsored pharmaceutical factory starts in Russia
31 May 2017
A ground-breaking ceremony of a pharmaceutical factory was held on Tuesday in Vorsino technology park located near the Russian city of Kaluga. American company Pfizer is an investor of the enterprise's building project.
According to TASS news agency, the main partner of the project is NovaMedica, a portfolio company of the Russian government-owned company Rusnano engaged in the development of nanotechnology.
Speaking at the ceremony, Chairman of Rusnano’s Board Anatoly Chubais said that NovaMedica has barely started the construction of its factory, but it is already having the sales volume amounting to 1 billion rubles on the Russian market.
A third of medical drugs that will be manufactured at the enterprise under a license of Pfizer are not currently produced in the territory of Russia.
PrintShareholders
Pipeline
Media Center
-
Rethinking of institutional, public health response needed to prevent next pandemic
26 July 2021
-
Novel coating requires no donor material to regenerate bones
26 July 2021
-
New Russian proctology medicine makes inroads in EU markets
26 July 2021
-
Apoptosis inhibitors show promise in severe TB models
23 July 2021